Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ECIAOTCMKTS:ESMCOTCMKTS:MICRNASDAQ:OSRH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECIAEncision$0.37$0.37$0.16▼$0.50$4.35M0.54604 shsN/AESMCEscalon Medical$0.35+12.0%$0.30$0.11▼$0.46$2.60M0.471,692 shs400 shsMICRMicron Solutions$0.00$0.00$0.00▼$1.00N/A0.4N/A1,000 shsOSRHOSR$1.35+8.0%$1.33$1.02▼$13.40$26.02M1.61109,975 shs82,155 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECIAEncision0.00%+22.00%+4.57%-23.43%-12.86%ESMCEscalon Medical0.00%-4.32%-24.28%+125.44%+118.75%MICRMicron Solutions0.00%0.00%0.00%-50.00%-99.98%OSRHOSR0.00%-12.34%+10.66%-43.75%+134,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/AESMCEscalon Medical0.6833 of 5 stars0.05.00.00.00.00.01.3MICRMicron Solutions0.1889 of 5 stars0.03.00.00.00.01.70.0OSRHOSRN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECIAEncision 0.00N/AN/AN/AESMCEscalon Medical 0.00N/AN/AN/AMICRMicron Solutions 0.00N/AN/AN/AOSRHOSR 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECIAEncision$6.59M0.66N/AN/A$0.15 per share2.44ESMCEscalon Medical$11.98M0.22$0.04 per share9.71$0.17 per share2.06MICRMicron Solutions$22.57M0.00N/AN/AN/A∞OSRHOSRN/AN/AN/AN/A($3.87) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECIAEncision-$690K-$0.04N/A∞N/A-8.96%-32.90%-15.51%7/14/2025 (Estimated)ESMCEscalon Medical-$130K$0.057.00∞N/A4.70%45.60%12.66%N/AMICRMicron Solutions-$1.29M-$0.43N/A∞N/AN/AN/AN/AN/AOSRHOSR-$2.41MN/A0.00∞N/AN/A-36.89%-19.14%N/ALatest ESMC, OSRH, MICR, and ECIA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025OSRHOSRN/A-$1.04N/A-$1.04N/A$0.76 million5/14/2025Q3 2025ESMCEscalon MedicalN/A$0.02N/A$0.02N/A$3.47 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthECIAEncisionN/AN/AN/AN/AN/AESMCEscalon MedicalN/AN/AN/AN/AN/AMICRMicron SolutionsN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECIAEncision0.111.670.82ESMCEscalon Medical0.141.921.23MICRMicron SolutionsN/AN/AN/AOSRHOSRN/A0.250.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECIAEncision8.20%ESMCEscalon MedicalN/AMICRMicron SolutionsN/AOSRHOSR55.30%Insider OwnershipCompanyInsider OwnershipECIAEncision36.75%ESMCEscalon Medical1.90%MICRMicron Solutions26.10%OSRHOSR33.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECIAEncision3011.88 million7.51 millionNot OptionableESMCEscalon Medical407.42 million7.27 millionNot OptionableMICRMicron Solutions1103.75 million2.77 millionNot OptionableOSRHOSRN/A19.28 million12.79 millionN/AESMC, OSRH, MICR, and ECIA HeadlinesRecent News About These CompaniesOSR Holdings, Inc. (OSRH)June 26 at 6:36 PM | uk.finance.yahoo.comOSRH OSR Holdings, Inc.June 4, 2025 | seekingalpha.comOSRH stock touches 52-week low at $1.07 amid market challengesMay 23, 2025 | investing.comOSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH TokenMay 22, 2025 | prnewswire.comDarnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative BiologicsMay 2, 2025 | prnewswire.comDarnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment TechnologyApril 9, 2025 | prnewswire.comOSR Holdings enters $80 mln stock purchase agreement with White Lion GBM Innovation FundApril 3, 2025 | msn.comOSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma TherapiesApril 3, 2025 | prnewswire.comDriving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease TreatmentMarch 28, 2025 | insurancenewsnet.comIOSR Holdings Inc.: Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in GlioblastomaMarch 26, 2025 | finanznachrichten.deOSR Holdings Inc.: OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific OfficerMarch 26, 2025 | finanznachrichten.deOSR Holdings Inc OSRHMarch 26, 2025 | morningstar.comMVaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in GlioblastomaMarch 26, 2025 | prnewswire.comOSR Holdings Appoints Dr. Constance Höfer as Chief Scientific OfficerMarch 25, 2025 | prnewswire.comMedia Sentiment Over TimeTop HeadlinesView All Headlines3 AI Infrastructure Stocks With Strong Growth, Not HypeBy Chris Markoch | June 26, 2025View 3 AI Infrastructure Stocks With Strong Growth, Not HypeWhy Super Micro Computer's Upside Could Trigger a Short SqueezeBy Gabriel Osorio-Mazilli | June 3, 2025View Why Super Micro Computer's Upside Could Trigger a Short Squeeze3 Penny Stocks Analysts Believe Are Headed HigherBy Chris Markoch | June 4, 2025View 3 Penny Stocks Analysts Believe Are Headed Higher3 Reasons AMD Could Be the Hottest Stock of the SummerBy Sam Quirke | June 20, 2025View 3 Reasons AMD Could Be the Hottest Stock of the SummerAnalysts Supercharge AMD Stock Ahead of Q2 AI CatalystBy Thomas Hughes | June 26, 2025View Analysts Supercharge AMD Stock Ahead of Q2 AI CatalystESMC, OSRH, MICR, and ECIA Company DescriptionsEncision OTCMKTS:ECIA$0.37 0.00 (0.00%) As of 06/27/2025Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.Escalon Medical OTCMKTS:ESMC$0.35 +0.04 (+12.00%) As of 06/27/2025 01:34 PM EasternEscalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.Micron Solutions OTCMKTS:MICR$0.0001 0.00 (0.00%) As of 06/27/2025 09:31 AM EasternMicron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.OSR NASDAQ:OSRH$1.35 +0.10 (+8.00%) As of 06/27/2025 04:00 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
